EuroBiotech—More Articles of Note


> Themis Bioscience set the range for an Amsterdam IPO that could raise upward of €40 million ($46 million). Statement 

> Invectys raised €15 million to run a phase 2 trial of its DNA cancer vaccine. FiercePharma

> ProQr licensed the global rights to an ophthalmology drug candidate from Ionis. Release

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.

> Transgene teamed up with NEC to access an AI platform. Statement  

> The European Investment Bank agreed to loan Newron Pharmaceuticals up to €40 million. Release